investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting the cytokine circuitry of KRAS-driven lung cancer
David A Barbie
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David A Barbie
Dana-Farber Cancer Institute
Boston, United States
Related projects
Raymond B Birge
Non-canonical signal pathway for Crk in breast cancer
Trachea, bronchus and lung
David Kozono
Characterization of lung cancer radiosensitizers from genome-wide RNAi screens
Trachea, bronchus and lung
Yanxiang Guo
The role of autophagy in Kras-driven lung cancer
Trachea, bronchus and lung
Pathology
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Trachea, bronchus and lung
Matthew L. Meyerson
How do genome alterations cause human lung cancer?
Trachea, bronchus and lung
Alexander D Sorkin
Pathogenesis of Cancer: Role of EGF Receptor Endocytosis
Trachea, bronchus and lung
Pathology
Matthew L. Meyerson
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
Trachea, bronchus and lung
Dennis Klinman
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
Trachea, bronchus and lung
Kwok Kin Wong
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
Trachea, bronchus and lung